Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.


Yildiz E., Ozkan M. U., Bektas G., Uzunhan T. A., Aydinli N., Caliskan M., ...More

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, vol.33, no.11, pp.2023-2027, 2017 (SCI-Expanded) identifier identifier identifier

Abstract

Lacosamide (LCM) is an effective antiepileptic drug (AED) approved for the treatment of focal epilepsy in both children and adults. The aim of this observational study was to review our centre's experience with LCM and to characterise its efficacy and tolerability as an adjunct therapy in children with refractory focal epilepsy.